论文部分内容阅读
近期发表的一项研究结果表明,治疗慢性丙型肝炎的新联合疗法首次在临床上获得成功,这一成功可以大大地改进与健康相关的生活质量。全世界大约有1亿人感染丙型肝炎病毒,7O％的被感染者患慢性丙型肝炎。唯一有效的干扰素短程(6 个月)治疗能使约4O％的病人
A recently published study shows that for the first time a new combination therapy for chronic hepatitis C is clinically successful, this success can greatly improve the health-related quality of life. About 100 million people worldwide are infected with the hepatitis C virus and 70% of the infected people have chronic hepatitis C. The only effective short-range interferon (6 months) treatment can make about 4O% of patients